Activation of human lung semicarbazide sensitive amine oxidase by a low molecular weight component present in human plasma

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1638, Issue 3, 2003, Pages 278-286

  Dalfo E ^a   Hernandez, M ^a   Lizcano, J M ^a   Tipton, K F ^b   Unzeta, M ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Activation; Lysophosphatidylcholine; Plasma component; Semicarbazide sensitive amine oxidase

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); CHYMOTRYPSIN; FORMIC ACID; LIPID; LYSOPHOSPHATIDYLCHOLINE; PERCHLORIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; TRYPSIN;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; HEART INFARCTION; HUMAN; HUMAN TISSUE; KINETICS; LUNG; MOLECULAR WEIGHT; PLASMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; BLOOD; BURN; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME STABILITY; ENZYMOLOGY; IN VITRO STUDY; METABOLISM; PH;

MAMMALIA;

AMINE OXIDASE (COPPER-CONTAINING); BURNS; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; LUNG; LYSOPHOSPHATIDYLCHOLINES; MYOCARDIAL INFARCTION; PHOSPHOLIPIDS;

EID: 0141432196     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(03)00094-2     Document Type: Article

References (48)

1. Precious E., Gunn C.E., Lyles G.A. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rata aorta. Biochem. Pharmacol. 37:1988;707-713.
2. Lizcano J.M., Fernandez de Arriba A., Lyles G.A., Unzeta M. Several aspects on the amine oxidation by semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. J. Neural Transm. 41:1994;415-420. (Supplement).
3. Lyles G.A. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. Int. J. Cell. Biol. 28:1996;259-274.
4. Houen G. Mammalian Cu-containing amine oxidases (CAOs): new methods of analysis, structural relationships and possible functions. APMIS. 107(Suppl. 96):1999;5-46.
5. Lewinsohn R. Mammalian monoamine oxidizing enzymes with special reference to benzylamine oxidase in human tissues, Brazil. J. Med. Biol. Res. 17:1984;223-256.
6. Precious E., Lyles G.A. Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery. J. Pharm. Pharmacol. 40:1988;627-633.
7. Hysmith R.M., Boor J.P. In vitro expression of benzylamine oxidase activity in cultured porcine smooth muscle cells. J. Cardiovasc. Pharmacol. 9:1987;674-688.
8. Fernandez de Arriba A., Lizcano J.M., Balsa M., Unzeta M. Contribution of different amine oxidases to the metabolism of dopamine in bovine retina. Biochem. Pharmacol. 42:1991;2355-2361.
9. Nordqvist A., Oreland L., Fowler C.J. Some properties of monoamine oxidase and a semicarbazide sensitive amine oxidase capable of the deamination of 5-hydroxytryptamine from porcine dental pulp. Biochem. Pharmacol. 31:1982;2739-2744.
10. Lyles G.A., Bertie K.H. Properties of a semicarbazide-sensitive amine oxidase in rat articular cartilage. Pharmacol. Toxicol. 60(Suppl. 1):1987;33.
11. Barr M.A., Callingham B.A. Solubilization and some properties of a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat. Biochem. J. 222:1984;467-475.
12. Andres N., Lizcano J.M., Rodriguez M.J., Romera M., Unzeta M., Mahy N. Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase. J. Histochem. Cytochem. 49:2001;209-217.
13. Lizcano J.M., Balsa D., Tipton K.F., Unzeta M. Amine oxidase activities in bovine lung. J. Neural Transm. 32:1990;341-344. (Supplement).
14. Lizcano J.M., Tipton K.F., Unzeta M. Purification characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. Biochem. J. 331:1998;69-78.
15. Lizcano J.M., Fernandez de Arriba A., Lyles G.A., Unzeta M. Several aspects on the amine oxidation by semicarbazide-sensitive amine oxidase from bovine lung. J. Neural Transm. 41:1994;415-420. (Supplement).
16. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:1993;2005-2015.
17. Enrique-Tarancon G., Marti L., Morin N., Lizcano J.M., Unzeta M., Sevilla L., Camps C.M., Palacin M., Testar X., Carpené C., Zorzano A. Role of semicarbazide-sensitive amine oxidase on glucose transport GLUT4 recruitment to the cell surface in adipose cells. J. Biol. Chem. 273:1998;8025-8032.
18. Smith D.J., Salmi M., Bono P., Hellman J., Leu T., Jalkanen S. Vascular adhesion protein-1 reveals a novel multifunctional adhesion molecule. J. Exp. Med. 188:1998;17-27.
19. Salmi M., Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science. 257:1992;1407-1409.
20. Jaakola K., Kaunismäki T., Tohka S., Yegutkin G., Vänttinen E., Havia T., Pelliniemi L.J., Virolainen M., Jalkanen S., Salmi M. Human vascular adhesion protein-1 in smooth muscle cells. Am. J. Pathol. 155:1999;1953-1965.
21. Boomsma F., van Veldhuisen D.J., de Kam P.J., Man in 't Veld A.J., Mosterd K.I., Lie D.H., Schalekamp M.A. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc. Res. 33:1997;387-391.
22. Lizcano J.M., Escrich E., Ribalta T., Muntane J., Unzeta M. Amine oxidase activities in rat breast cancer induced experimentally with 7,12-dimethylbenz (α) anthracene. Biochem. Pharmacol. 42:1991;263-269.
23. Hayes B.E., Clarke D.E. Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res. Commun. Chem. Pathol. Pharmacol. 69:1990;71-83.
24. Yu P.H., Zuo D.M. Oxidative deamination of methylamine by SSAO leads to cytotoxic damage in endothelial cells. Diabetes. 42:1993;594-606.
25. Thomas P.K. Diabetic neuropathy: models mechanisms and mayhem. Can. J. Sci. 19:1992;1-7.
26. Garpenstrand H., Ekblom J., Bäcklund A., Oreland L., Rosenqvist T. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in type 2 diabetes mellitus complicated by retinopathy. Diabet. Med. 16:1999;514-521.
27. Yu P.H., Lai C.T., Zuo M.D. Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem. Res. 22:1997;615-620.
28. Fowler C.J., Tipton K.F. Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase. Biochem. Pharmacol. 30:1981;3329-3332.
29. Precious E., Gunn C.E., Lyles G.A. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem. Pharmacol. 37:1988;707-713.
30. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
31. McDonald A.G., Tipton K.F. Kinetics of catalyzed reactions - biological. Horváth I.T. Encyclopedia of Catalysis. 2002;Wiley, New York, NY. http://www.mrw.interscience.wiley.com/enccat/ (DOI: 0.1002/0471227617.eoc127).
32. Gillet M.P.T., Obineche E.N., Lakhani M.S., Abdulle A.M., Amirlak I., Alrukhaimi M., Suleiman M.N. Levels of cholesteryl esters and other lipids in the plasma of patients with end-stage renal failure. Ann. Saudi Med. 21:2001;283-286.
33. Berrettini W.H., Vogel W.H. Evidence for an endogenous inhibition of platelet MAO in chronic schizophrenia. Am. J. Psychiatry. 135:1978;605-607.
34. Yu P.H., Boulton A.A. Activation of platelet monoamine oxidase by plasma in the human. Life Sci. 25:1979;31-36.
35. Whalund L.O., Sääf J., Ross S.B., Wetterberg L. Activation of monoamine oxidase by high molecular weight fractions of human plasma. Acta Physiol. Scand. 120:1984;337-341.
36. Buffoni F., Banchelli G., Ignesti G., Pirisino R. The presence of an inhibitor of benzylamine oxidase in human blood plasma. Biochem. J. 211:1983;767-769.
37. Fitzgerald D.H., Tipton K.F. Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO). J. Neural Transm. 109:2002;251-265.
38. Quinn M.T.S., Parthasarathy S., Steinberg D. Lysophosphatidylcholine; a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. U. S. A. 85:1988;3805-3809.
39. Liu S.Y.X., Lu X., Choy S., Dembinski T.C., Hatch G.M., Mymin D., Shen X., Angel A., Choy P.C., Man R.Y. Alteration of lysophosphatydilcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation. Cardiovasc. Res. 28:1994;1476-1481.
40. Sekas G., Pallon G.M., Lincoln C.C., Robins S.J. Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat. J. Lab. Clin. Med. 105:1985;190-194.
41. Nelson G.J. Composition of neutral lipids from erythrocytes of common mammals. J. Lipid Res. 8:1967;374-379.
42. Katz A.M., Messineo F.C. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ. Res. 48:1981;1-16.
43. Yuan Y., Schenwawlder S.M., Salem H.H., Jackson S.P. The bioactive phospholipid, lysophosphatidylcholine induces cellular effects via G-protein dependent activation of adenyl cyclase. J. Biol. Chem. 271:1996;27090-27098.
44. Hirata K., Miki N., Kuroda Y., Sakoda T., Kawashima S., Yokoyama M. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cell. Circ. Res. 76:1995;958-962.
45. Chai Y.C., Howe P.H., DiCorleto P.E., Chisolm G.M. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells: evidence for release of FGF-2. J. Biol. Chem. 271:1996;17791-17797.
46. Colles S.M., Guy M., Chisolm G.M. Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative event. J. Lipid Res. 41:2000;1188-1198.
47. 2+-ATPase in asthma. Clin. Sci. 97:1999;595-601.
48. Souto R.P., Vallega G., Wharton J., Vinten J., Tranum-Jensen J., Pilch P.F. Immunopurification and characterization of rat adipocyte caveolae suggest their dissociation from insulin signaling. J. Biol. Chem. 278:2003;18321-18329.